Ideas
Buy J&J for medtech rotation.
The market is rotating away from traditional tech and data center exposure. Johnson & Johnson represents medtech, a technological company outside the tech sector that benefits from lower oil prices and offers diversification from AI/data center risks.
Avoid new Nvidia, history is against it.
Nvidia's involvement in vendor financing for customer data center purchases, such as guaranteeing $250 billion for OpenAI, echoes the dotcom era where suppliers lent to buyers who later defaulted. Even though Nvidia's balance sheet is strong, history suggests the stock market will punish the stock and institutions will keep selling. Hold existing positions but do not buy more.
Buy Intel on CPU/foundry turnaround.
Intel is being bought aggressively for the CNBC Investing Club. Reasons: CPUs will be used more than GPUs, CEO Lip Bu Tan is focusing on packaging (validated by Cadence Design's strong quarter), and the world is short foundry space which Lip Bu Tan knows how to build.
Own CrowdStrike for cybersecurity leadership.
CrowdStrike is a leading cybersecurity company with an open model. Despite a dip on Microsoft's cybersecurity moves, CEO George Kurtz is the foremost person in cybersecurity and the stock is an "own".
Buy American Express on post-earnings dip.
American Express sold off after beating earnings but not raising guidance, which is a misguided reaction. The bill business is strong with millennial spending up 14% and Gen Z up 40%, credit metrics are fantastic, and management wisely reinvests for growth. Down 13% from all-time high, this is a terrific buying opportunity.
Buy Solstice Advanced Materials on pullback.
Solstice Advanced Materials is a spin-off from Honeywell that initially surged then fell back after announcing a merger with Element Solutions. Despite the pullback to the $60s, Cramer still thinks it's a buy.
Watch Honeywell Technologies after strong quarter.
Honeywell Technologies delivered a strong quarter with accelerating orders, expanding margins, and raised full-year forecasts. It can now hit long-term targets and deserves a higher multiple, but the stock has had a big run making it harder to recommend at these levels. The charitable trust is holding.
Buy Honeywell Aerospace on pullback.
Honeywell Aerospace is the crown jewel of the old Honeywell, with enormous backlogs at Boeing and Airbus, defense and space exposure, and organic growth targets of 6-8%. The stock has been slammed due to oil but trades at 21x earnings, a discount to peers GE Aerospace (40x) and RTX (28x). The charitable trust is using the pullback to add, and it is an incredible buying opportunity.
Buy CR for infrastructure away from tech.
CR is the largest aggregates producer in North America, with a connected portfolio that includes asphalt, paving, and water/energy infrastructure. The business is less exposed to data centers and more to mandatory road maintenance, providing recurring revenue. The stock is down due to higher oil and rates, offering a long-term opportunity.
Buy First Horizon, very inexpensive.
First Horizon is a regional bank stock that is very inexpensive and a terrific buy.
Avoid Nike, just okay.
Nike is trying to turn around but faces a lot of competition. The charitable trust sold it because it's just "okay" and they don't want to own just okay.
Avoid Keer Insurance, no growth.
Keer Insurance offers a 4% yield but lacks growth. Cramer doesn't want to own it because he needs growth, so he's avoiding it.
This CNBC video, published July 28, 2026,
features Jim Cramer
discussing JNJ, NVDA, INTC, CRWD, AXP, Solstice Advanced Materials, Honeywell Technologies, Honeywell Aerospace, CR, FHN, NKE, KN&P.
12 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Jim Cramer
· Tickers:
JNJ,
NVDA,
INTC,
CRWD,
AXP,
Solstice Advanced Materials,
Honeywell Technologies,
Honeywell Aerospace,
CR,
FHN,
NKE,
KN&P